Jie Gan
Corporate Officer/Principal at The Hong Kong University of Science & Technology
Jie Gan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Career history of Jie Gan
Former positions of Jie Gan
| Companies | Position | Start | End |
|---|---|---|---|
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Director/Board Member | - | 07/01/2010 |
Training of Jie Gan
| Peking University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Statistics
International
| China | 4 |
| United States | 2 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Jie Gan
- Experience
